IVF Stimulation Protocols and Outcomes in Women with Endometriosis

In: Endometriosis-related Infertility · 2024 · pp. 199–207 · doi:10.1007/978-3-031-50662-8_15 · W4392309798
book-chapter OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
AI-generated summary by claude@2026-06+body, 2026-06-07

Endometriosis presents challenges for fertility, and while various IVF stimulation protocols like long, antagonist, and PPOS exist, none are definitively superior, though early intervention is beneficial.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07

This 2024 chapter reviews how different ovarian stimulation approaches for IVF in women with endometriosis compare in outcomes, focusing on long (GnRH agonist) versus antagonist protocols and newer progesterone-primed only (PPOS) strategies, alongside the impact of advances like embryo vitrification. It synthesizes evidence suggesting that no single protocol has been proven superior, while noting that antagonist regimens are shorter and described as safer, and PPOS may offer safety and cost/compliance advantages. A key caveat stated is that the evidence base remains unsettled—ongoing debate persists—and protocol comparisons may not yield a clear winner across studies. This paper is centrally about endometriosis — it reviews IVF stimulation protocol choices (long vs antagonist vs PPOS) and their reported outcomes in women with endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (21)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK